MOM 7 → 8 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] Real AMFI 1Y return vs Nifty Smallcap 250 TRI: +15.75pp — real, strong outperformance, though only a single window is available given the fund's short history.”
CON 7 → 0 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] Confirmed UNRATED by Value Research directly on its own fund page. Scored 0 (N/A).”
PQT 6 → 6 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] Real top-5 holdings: Rubicon Research 4.43%, VA Tech Wabag 4.03%, Karur Vysya Bank 3.48%, CCL Products 3.36%, Aditya Infotech 3.25% (top-5 total 18.55%) — diversified across pharma/CDMO, water treatment/EPC, banking, coffee/FMCG, and electronics/security.”
FMQ 5 → 5 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] Real 5-manager team, managing since December 26, 2023 — under 2 years, no independent track record yet.”
VAL 5 → 0 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] No PE/PB evidence found on the fund's own VR page. Scored 0 (N/A).”
STW 6 → 6 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] Real portfolio diversified across pharma/CDMO, water/EPC, banking, FMCG, and electronics — a genuine, currently-relevant broad small-cap exposure.”
DSP 5 → 0 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] No real drawdown/Sortino evidence found on the fund's own VR page. Scored 0 (N/A).”
OPP 7 → 5 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION, analyst judgment] Real strong recent performance is a genuine positive, but the fund is unrated with no independent long-term track record — scored at a moderate rather than high level.”
THS 5 → 4 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 10:02:17 AM
“[FINAL CHALLENGER VALIDATION] Standard, real, diversified small-cap thesis; too early (under 2 years, unrated) to assess durable execution against it.”
THS ∅ → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:28 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Small Cap: highest growth potential in the equity spectrum, but also the highest liquidity and drawdown risk in stress.”
OPP ∅ → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:27 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real return-vs-benchmark evidence: 1Y +15.75pp vs benchmark, SinceLaunch +11.74pp vs benchmark (avg 13.75pp).”
DSP ∅ → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:25 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No real Max Drawdown or Sortino data exists in any source checked this session; ordinary volatility/beta are never substituted.”
STW ∅ → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:23 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Category-level thesis: Small Cap: highest growth potential in the equity spectrum, but also the highest liquidity and drawdown risk in stress. No fund-specific sector-overweight evidence collected (no GICS sector allocation data exists for this scheme), so scored at the category's own general positioning.”
VAL ∅ → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:21 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No real TER data collected; scored at category-neutral baseline (no portfolio PE/PB data exists in any source checked this session).”
FMQ ∅ → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:20 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No manager identity evidence collected; scored at category-neutral baseline.”
PQT ∅ → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:18 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real AUM ₹7,990.1 Cr vs category floor ₹500 Cr (16.0x). Moderate scale — no specific capacity concern or advantage documented.”
CON ∅ → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:16 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No Value Research rating collected; consistency estimated from real return-vs-benchmark trend (1Y +15.75pp vs benchmark, SinceLaunch +11.74pp vs benchmark, avg 13.75pp).”
MOM ∅ → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:14 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Most recent available window (1Y: +15.75pp vs benchmark) used as the closest real proxy for near-term momentum (V6's exact 3-6M window has no data source for most equity funds in this pipeline).”